WASHINGTON-Endocrine Society members elected Carol Lange, Ph.D., of the University of Minnesota in Minneapolis, Minnesota, as their 2025-2026 president. She will serve as president-elect for one year starting in June 2024 before becoming president in June 2025.
Lange is Professor of Medicine and Molecular Pharmacology and Therapeutics, Tickle Family Land Grant Endowed Chair in Breast Cancer Research, and Associate Director for Basic Sciences and Director of the Molecular, Genetic, and Cellular Targets of Cancer Training Program at The University of Minnesota Masonic Cancer Center in Minneapolis , Minnesota. Her research focus is on the role of steroid hormone receptors in breast and ovarian cancer.
She is a passionate mentor to trainees at all levels and has held many leadership positions within the Endocrine Society. She is currently editor-in-chief of the society’s journal, Endocrinology. During her tenure as Chair of the Annual Basic Sciences Meeting Steering Committee, she helped found the annual Trainee Day at ENDO, an event that fosters the next generation of endocrine researchers. For all her contributions, she also received the Society’s Sidney H. Ingbar Laureate Award for Distinguished Service to the Field of Endocrinology.
The Society also selected four additional members to join its Board of Directors beginning in June 2024:
- Kristy Brown, Ph.D., University of Kansas Medical Center, Shawnee, Kan.: Brown was selected for the position of Secretary/Treasurer of the Society. She is an associate professor of metabolism and cancer in the Department of Cell Biology and Physiology at the University of Kansas Medical Center and co-program director for cancer prevention and control at the University of Kansas Cancer Center. She is internationally known for her work investigating the molecular connection between obesity and breast cancer. Brown has long been involved in the Endocrine Society, including helping develop the latest strategic plan and serving as a member of the Basic Science Advisory Group and Basic Science Chair for ENDO 2018. She is currently an Associate Editor for Endocrinology and a member of the Finance Committee – and audit committee of the company.
- Bruno Ferraz-de-Souza, MD, Ph.D., University of Notre Dame Australia, Fremantle, Australia: Ferraz-de-Souza is Associate Professor and Chair of Basic and Clinical Sciences at the University of Notre Dame Australia School of Medicine in Fremantle, Western Australia, and Honorary Principal Investigator and Postgraduate Supervisor in Endocrinology at the University of Sao Paulo School of Medicine, in Sao Paulo, Brazil. His recent research addresses the molecular basis of rare and common endocrinopathies, with a focus on bone metabolism. He is currently co-editor of the Journal of the Endocrine Society and chair of the Publications Core Committee. He also chaired the Diversity and Inclusion Committee.
- Lauren Fishbein, MD, Ph.D., University of Colorado School of Medicine, Aurora, Colorado.: Fishbein is an associate professor of medicine at the University of Colorado School of Medicine in the Division of Endocrinology, Metabolism and Diabetes with a secondary appointment in the Division of Biomedical Informatics and director of the Neuroendocrine Tumor Clinical and Research Program. Her research interest is in understanding what causes neuroendocrine tumors to develop. She has held many service positions within the Society and is currently Chair of the ENDO 2024 Annual Meeting, Associate Editor of Endocrine Reviews, and a member of the Society’s Core Research Affairs Committee.
- Angela Leung, MD, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, California.: Leung is an associate professor of medicine in the Division of Endocrinology, Diabetes and Metabolism in the School of Medicine, David Geffen School of Medicine, University of California, Los Angeles and the Veterans Affairs Greater Los Angeles Healthcare System. Her research interests include thyroid disease, iodine status, maternal-fetal thyroid health, and environmental thyroid toxins. She is currently an editorial board member of the Journal of Clinical Endocrinology & Metabolism and a faculty member of the Society’s Endocrine Self-Assessment Program.
The board members then begin their three-year term of office ENDO 2024. The Company’s annual meeting will be held June 1-4, 2024 in Boston, Massachusetts.
# # #
Endocrinologists are at the heart of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists dedicated to hormone research and physicians caring for people with hormone-related diseases.
The society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the society and the field of endocrinology, visit our website at www.endocrine.org. Follow us on Twitter at @TheEndoSociety And @EndoMedia.